|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1979-10-18 |
Phase I Study of Safety and Pharmacokinetics of Once-Daily Topical Solution in Male Subjects With Androgenetic Alopecia
This study will be a single center, open-label study of a single concentration of ANR- 001.1. The solution will be applied to the scalp of 14 male subjects by study staff once daily for 7 days.
Proof of Concept of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation for Eyebrows
Study to Evaluate the safety and efficacy of a Latanoprost/Minoxidil formulation vs. placebo for the treatment of hypotrichosis of the eyebrows.
100 项与 Aneira Pharma, Inc. 相关的临床结果
0 项与 Aneira Pharma, Inc. 相关的专利(医药)
100 项与 Aneira Pharma, Inc. 相关的药物交易
100 项与 Aneira Pharma, Inc. 相关的转化医学